Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal

Joanne Katz, Janet A Englund, Mark C Steinhoff, Subarna K Khatry, Laxman Shrestha, Jane Kuypers, Luke C Mullany, Helen Y Chu, Steven C LeClerq, Naoko Kozuki, James M Tielsch, Joanne Katz, Janet A Englund, Mark C Steinhoff, Subarna K Khatry, Laxman Shrestha, Jane Kuypers, Luke C Mullany, Helen Y Chu, Steven C LeClerq, Naoko Kozuki, James M Tielsch

Abstract

Background: Maternal influenza vaccination protects mothers and their infants in low resource settings, but little is known about whether the protection varies by gestational age at vaccination.

Methods: Women of childbearing age in rural southern Nepal were surveilled for pregnancy, consented and randomized to receive maternal influenza vaccination or placebo, with randomization stratified on gestational age (17-25 or 26-34 weeks). Enrollment occurred in 2 annual cohorts, and vaccinations occurred from April 2011 through September 2013.

Results: In sum, 3693 women consented and enrolled, resulting in 3646 live births. Although cord blood antibody titers and the rise in maternal titers were generally greater when women were vaccinated later in pregnancy, this was not statistically significant. The incidence risk ratio (IRR) for maternal influenza in pregnancy through 6 months postpartum was 0.62 (95% confidence interval [CI]: 0.35, 1.10) for those vaccinated 17-25 weeks gestation and 0.89 (95% CI: 0.39, 2.00) for those 26-34 weeks. Infant influenza IRRs were 0.73 (95% CI: 0.51, 1.05) for those whose mothers were vaccinated earlier in gestation, and 0.63 (95% CI: 0.37, 1.08) for those later. Relative risks (RR) for low birthweight were 0.83 (95% CI: 0.71, 0.98) and 0.90 (95% CI: 0.72, 1.12) for 17-25 and 26-34 weeks gestation at vaccination, respectively. IRRs did not differ for small-for-gestational age or preterm. No RRs were statistically different by timing of vaccine receipt.

Conclusions: Vaccine efficacy did not vary by gestational age at vaccination, making maternal influenza immunization programs easier to implement where women present for care late in pregnancy.

Clinical trials registration: NCT01034254.

References

    1. Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012; 207:S3–8.
    1. Fell DB, Savitz DA, Kramer MS, et al. . Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG 2017; 124:48–59.
    1. World Health Organization. Vaccines against influenza, WHO position paper – Weekly Epidemiological Record, 2012; 87;461–76.
    1. Zaman K, Roy E, Arifeen SE, et al. . Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555–64.
    1. Madhi SA, Cutland CL, Kuwanda L, et al. ; Maternal Flu Trial (Matflu) Team Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918–31.
    1. Tapia MD, Sow SO, Tamboura B, et al. . Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis 2016; 16(9):1026–1035. doi: 10.1016/S1473-3099(16)30054–8.
    1. Steinhoff MC, Katz J, Englund JA, et al. . Year-round influenza immunization in pregnancy: a randomized placebo-controlled trial in Nepal. Lancet Inf Dis 2017. doi: 10.1016/S1473-3099(17)30252–9.
    1. Steinhoff MC, Omer SB, Roy E, et al. . Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 2012; 184:645–53.
    1. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine 1998; 16:1456–63.
    1. Jackson LA, Patel SM, Swamy GK, et al. . Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 204:854–63.
    1. Tsatsaris V, Capitant C, Schmitz T, et al. ; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med 2011; 155:733–41.
    1. Nunes MC, Cutland CL, Dighero B, et al. ; Matflu Team Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis 2015; 212:1976–87.
    1. Omer SB, Richards JL, Madhi SA, et al. ; BMGF Supported Maternal Influenza Immunization Trials Investigators Group Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: methods and expectations. Vaccine 2015; 33:3801–12.
    1. Tielsch JM, Steinhoff M, Katz J, et al. . Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal. BMC Pregnancy Childbirth 2015; 15:40.
    1. Villar J, Cheikh Ismail L, Victora CG, et al. . International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn cross-sectional study of the INTERGROWTH-21st Project. Lancet 2014; 384:857–68.
    1. Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study. Pediatr Infect Dis J 2016; 35:1097–103.
    1. Arriola CS, Vasconez N, Thompson MG, et al. . Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua. Vaccine 2017; 35:3056–63.
    1. Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F; Vaccine Safety Datalink Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164:1051–1057.e2.
    1. Sperling RS, Engel SM, Wallenstein S, et al. . Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol 2012; 119:631–9.
    1. Eberhardt CS, Blanchard-Rohner G, Lemaître B, et al. . Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis. Clin Infect Dis 2016; 62:829–36.
    1. Eberhardt CS, Blanchard-Rohner G, Lemaître B, et al. . Pertussis antibody transfer to preterm neonates after second- versus third-trimester maternal immunization. Clin Infect Dis 2017; 64:1129–32.
    1. Gernand AD, Paul RR, Ullah B, et al. . A home calendar and recall method of last menstrual period for estimating gestational age in rural Bangladesh: a validation study. J Health Popul Nutr 2016; 35:34.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe